Enriched Signalling Pathways in Venetoclax-Relapsed Chronic Lymphocytic Leukemia (CLL) Cells and Targeting Using a Protac-Based Bcl-2/Bcl-Xl Degrader
Daisy Diaz Rohena(The University of Texas MD Anderson Cancer Center), Deepa Sampath(The University of Texas MD Anderson Cancer Center), Nitin Jain(Parul University), Janani Ravikrishnan(The Ohio State University), Guangrong Zheng(Kunming Medical University), Bailey Slawin(The University of Texas MD Anderson Cancer Center), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Philip A. Thompson(The Royal Melbourne Hospital), Charmelle D. Williams(The University of Texas MD Anderson Cancer Center), William G. Wierda(University of Maryland, Baltimore), Daohong Zhou(The University of Texas at San Antonio Health Science Center), Peiyi Zhang(University of Florida), Chaomei Liu(The University of Texas MD Anderson Cancer Center), Jennifer A. Woyach(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Arnau Peris Cuesta(The University of Texas MD Anderson Cancer Center), Wanyi Hu(Dana-Farber Cancer Institute)
Cited by 1